These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease. Martinez-Horta S; Perez-Perez J; van Duijn E; Fernandez-Bobadilla R; Carceller M; Pagonabarraga J; Pascual-Sedano B; Campolongo A; Ruiz-Idiago J; Sampedro F; Landwehrmeyer GB; ; Kulisevsky J Parkinsonism Relat Disord; 2016 Apr; 25():58-64. PubMed ID: 26898966 [TBL] [Abstract][Full Text] [Related]
3. Apathy and depression in mild cognitive impairment: distinct longitudinal trajectories and clinical outcomes. Connors MH; Teixeira-Pinto A; Ames D; Woodward M; Brodaty H Int Psychogeriatr; 2023 Nov; 35(11):633-642. PubMed ID: 36715000 [TBL] [Abstract][Full Text] [Related]
4. Distinguishing apathy and depression in dementia: A longitudinal study. Connors MH; Teixeira-Pinto A; Ames D; Woodward M; Brodaty H Aust N Z J Psychiatry; 2023 Jun; 57(6):884-894. PubMed ID: 35968798 [TBL] [Abstract][Full Text] [Related]
5. Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY). van Duijn E; Craufurd D; Hubers AA; Giltay EJ; Bonelli R; Rickards H; Anderson KE; van Walsem MR; van der Mast RC; Orth M; Landwehrmeyer GB; J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1411-8. PubMed ID: 24828898 [TBL] [Abstract][Full Text] [Related]
6. Apathy Profile in Parkinson's and Huntington's Disease: A Comparative Cross-Sectional Study. Sousa M; Moreira F; Jesus-Ribeiro J; Marques I; Cunha F; Canário N; Freire A; Januário C Eur Neurol; 2018; 79(1-2):13-20. PubMed ID: 29131091 [TBL] [Abstract][Full Text] [Related]
7. A systematic review and meta-analysis of depression and apathy frequency in adult-onset Huntington's disease. Clark ML; Abimanyi-Ochom J; Le H; Long B; Orr C; Khanh-Dao Le L Neurosci Biobehav Rev; 2023 Jun; 149():105166. PubMed ID: 37054804 [TBL] [Abstract][Full Text] [Related]
9. Bupropion for the treatment of apathy in Huntington's disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial. Gelderblom H; Wüstenberg T; McLean T; Mütze L; Fischer W; Saft C; Hoffmann R; Süssmuth S; Schlattmann P; van Duijn E; Landwehrmeyer B; Priller J PLoS One; 2017; 12(3):e0173872. PubMed ID: 28323838 [TBL] [Abstract][Full Text] [Related]
10. Exploring the predictors of financial impairment in Huntington's disease using the Enroll-HD dataset. Harris KL; Mason SL; Barker RA J Neurol; 2022 Jul; 269(7):3501-3510. PubMed ID: 35165768 [TBL] [Abstract][Full Text] [Related]
11. On the association between apathy and deficits of social cognition and executive functions in Huntington's disease. Hendel RK; Hellem MNN; Hjermind LE; Nielsen JE; Vogel A J Int Neuropsychol Soc; 2023 May; 29(4):369-376. PubMed ID: 36189712 [TBL] [Abstract][Full Text] [Related]
12. Negative symptoms in Huntington's disease. Soliveri P; Paridi D; Del Sorbo F; Tramacere I; Girotti F Neurol Sci; 2022 Jun; 43(6):3695-3701. PubMed ID: 35067828 [TBL] [Abstract][Full Text] [Related]
13. The temporal dynamics of mood and their association with depressive symptoms in Huntington's disease. Bilal H; Harding IH; Stout JC J Affect Disord; 2023 May; 328():22-28. PubMed ID: 36791969 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease. Thompson JC; Harris J; Sollom AC; Stopford CL; Howard E; Snowden JS; Craufurd D J Neuropsychiatry Clin Neurosci; 2012; 24(1):53-60. PubMed ID: 22450614 [TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric aspects of Huntington's disease. Paulsen JS; Ready RE; Hamilton JM; Mega MS; Cummings JL J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):310-4. PubMed ID: 11511702 [TBL] [Abstract][Full Text] [Related]
16. Rating Apathy in Huntington’s Disease: Patients and Companions Agree. Mason S; Barker RA J Huntingtons Dis; 2015; 4(1):49-59. PubMed ID: 26333257 [TBL] [Abstract][Full Text] [Related]
17. Early-Motor Phenotype Relates to Neuropsychiatric and Cognitive Disorders in Huntington's Disease. Julayanont P; Heilman KM; McFarland NR Mov Disord; 2020 May; 35(5):781-788. PubMed ID: 31922295 [TBL] [Abstract][Full Text] [Related]
18. The Neuropsychiatry of Huntington Disease-Like 2: A Comparison with Huntington's Disease. Ferreira-Correia A; Krause A; Anderson DG J Huntingtons Dis; 2020; 9(4):325-334. PubMed ID: 33044188 [TBL] [Abstract][Full Text] [Related]
19. Mental health symptoms among those affected by Huntington's disease: A cross-sectional study. Gunn S; Dale M; Ovaska-Stafford N; Maltby J Brain Behav; 2023 Apr; 13(4):e2954. PubMed ID: 36880126 [TBL] [Abstract][Full Text] [Related]
20. Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington's Disease. Ellis N; Tee A; McAllister B; Massey T; McLauchlan D; Stone T; Correia K; Loupe J; Kim KH; Barker D; Hong EP; Chao MJ; Long JD; Lucente D; Vonsattel JPG; Pinto RM; Elneel KA; Ramos EM; Mysore JS; Gillis T; Wheeler VC; Medway C; Hall L; Kwak S; Sampaio C; Ciosi M; Maxwell A; Chatzi A; Monckton DG; Orth M; Landwehrmeyer GB; Paulsen JS; Shoulson I; Myers RH; van Duijn E; Rickards H; MacDonald ME; Lee JM; Gusella JF; Jones L; Holmans P Biol Psychiatry; 2020 May; 87(9):857-865. PubMed ID: 32087949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]